Grifols (GRFS)
(Delayed Data from NSDQ)
$10.78 USD
+0.08 (0.75%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $10.78 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Grifols, S.A. has a PEG ratio of 0.82 compared to the Medical - Drugs industry's PEG ratio of 2.05.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
GRFS 10.78 +0.08(0.75%)
Will GRFS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GRFS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GRFS
New Strong Sell Stocks for July 31st
Will Strong Asceniv Sales Drive ADMA Biologics Further?
GRFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?
ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold?
Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know
Other News for GRFS
Grifols S.A. declares $0.1404 dividend
Grifols reports Q2 revenue EUR 1.89B vs. EUR 1.79B last quarter
Grifols reinstates dividend of EUR 0.15 per share
Grifols affirms 2025 guidance from capital markets day
Grifols (GRFS) Reaffirms 2025 Outlook and Enhances Cash Flow Forecast